Regulatory

RSS

Vistide approved in U.S.

July 5, 1996

Phase III trials of Alferon N Injection initiated in HIV-positive patients

July 5, 1996

Nadolol/isosorbide monohydrate combination prevents rebleeding

June 28, 1996

Gabitril approved in France as add-on therapy

June 28, 1996

Depakote receives FDA approval for new indication

June 28, 1996

Virulizin undergoes phase I/II in pancreatic cancer

June 28, 1996

Eulexin is FDA-approved for new indication

June 28, 1996

DepoCyt earns positive phase III results

June 28, 1996

Zithromax approved by FDA for new indication

June 28, 1996

Viramune receives accelerated FDA approval

June 28, 1996